Skip to main content
OpenTrials

Clinical trial condition

Retroviridae Infections

Explore clinical trials studying Retroviridae Infections. Study availability and eligibility vary by location and protocol.

5,660 public trials 308 recruiting studies
Refine in advanced search Browse all conditions

Retroviridae Infections trial results

Completed

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

NCT00158405

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Centre de Prise en Charge et de Formation ACONDA Abidjan, Côte d’Ivoire
  • Centre de Suivi des donneurs de sang, Centre National de Transfusion Sanguine Abidjan, Côte d’Ivoire
  • Centre Intégré de Recherches Biocliniques d'Abidjan Abidjan, Côte d’Ivoire
  • Service des Maladies Infectieuses et Tropicales, CHU de Treichville Abidjan, Côte d’Ivoire
View Trial Details
Completed

Influenza Vaccination in Immunocompromized Patients

NCT00783380

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +18 more
Locations
  • Department of Infectious Diseases, Bern University Hospital Bern, Switzerland
  • Department of Nephrology/Hypertension, Bern University Hospital Bern, Switzerland
  • Department of Rheumatic Diseases, Bern University Hospital Bern, Switzerland
View Trial Details
Completed

Study to Evaluate the Replacement of Reverse Transcriptase Nucleoside/Nucleotide Inhibitors by Nevirapine in Patients on Triple Treatment With Analogues Only

NCT00415090

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Hospital.Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
  • Centre Penitenciari Brians Barcelona, Spain
  • Hopsital de Sant Pau Barcelona, Spain
  • Hospital Vall d'Hebron Barcelona, Spain
View all 17 locations
View Trial Details
Completed

Pharmacokinetic Study Of EPZICOM Tablet

NCT00337922

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Nagano, Japan
  • GSK Investigational Site Osaka, Japan
  • GSK Investigational Site Shizuoka, Japan
  • GSK Investigational Site Tokyo, Japan
View Trial Details
Completed

A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701

NCT00435838

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • GSK Investigational Site Graz, Austria
  • GSK Investigational Site Innsbruck, Austria
  • GSK Investigational Site Salzburg, Austria
  • GSK Investigational Site Vienna, Austria
View all 25 locations
View Trial Details

Related conditions